Skip to main content

Advertisement

Log in

How do cognitive and axial motor signs correlate in Parkinson’s disease? A 6-year prospective study

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Impairment of Parkinson’s disease (PD) axial motor signs (AMS) has been described as a risk factor for dementia. Executive dysfunction is an important feature in recently proposed clinical diagnostic criteria for PD dementia. To clarify the relationship between AMS progression and executive cognitive performance, we conducted a 6-year prospective study in PD patients without AMS impairment at baseline. A hospital-based cohort of PD patients (n = 24) without dementia, in the initial motor stage (Hoehn–Yahr ≤ 2), and matched controls (n = 20) were followed prospectively over a 6-year period. Neuropsychological tests were performed in both groups, and motor function (including AMS: speech, gait, postural instability) was evaluated in the PD group. The PD group had a significantly higher decline in neuropsychological test scores than did the controls. Most of the neuropsychological and motor decline occurred in the last 4 years. In UPDRS III, progression of AMS and especially speech were the most important motor variables related to dementia. There was a correlation between speech impairment progression and declines in MMSE (r = −0.598, p = 0.002), Clock Drawing (r = −0.671, p < 0.001), Semantic Verbal Fluency (r = −0.435, p = 0.034), Alternating Sequences (r = 0.497, p = 0.014), and Raven’s Coloured Progressive Matrices (r = −0.735, p < 0.001). PD patients with higher speech impairment progression showed more rapid declines in some neuropsychological tests. Further studies are needed to clarify the different roles of speech, gait and postural instability on the initial phases of cognitive dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P (2001) Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology 56:730–736

    PubMed  CAS  Google Scholar 

  2. Aarsland D, Andersen K, Larsen JP, Perry R, Wentzel-Larsen T, Lolk A, Kragh-Sorensen P (2004) The rate of cognitive decline in Parkinson disease. Arch Neurol 61:1906–1911. doi:10.1001/archneur.61.12.1906

    Article  PubMed  Google Scholar 

  3. Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D (2006) Changes in motor subtype and risk for incident dementia in Parkinson’s disease. Mov Disord 21:1123–1130. doi:10.1002/mds.20897

    Article  PubMed  Google Scholar 

  4. APA (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington (text revision)

    Google Scholar 

  5. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y (1987) Does long-term aggravation of Parkinson’s disease result from nondopaminergic lesions? Neurology 37:1539–1542

    PubMed  CAS  Google Scholar 

  6. Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404–1410

    PubMed  CAS  Google Scholar 

  7. Brink TL, Yesavage JA, Lum O, Heersema P, Adey MB, Rose TL (1982) Screening tests for geriatric depression. Clin Gerontol 1:37–44. doi:10.1300/J018v01n01_06

    Article  Google Scholar 

  8. Brusa L, Tiraboschi P, Koch G, Peppe A, Pierantozzi M, Ruggieri S, Stanzione P (2005) Pergolide effect on cognitive functions in early mild Parkinson’s disease. J Neural Transm 112:231–237. doi:10.1007/s00702-004-0193-0

    Article  PubMed  CAS  Google Scholar 

  9. Burn DJ, Rowan EN, Allan LM, Molloy S, O’Brien JT, McKeith IG (2006) Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 77:585–589. doi:10.1136/jnnp.2005.081711

    Article  PubMed  CAS  Google Scholar 

  10. Carlson MC, Xue QL, Zhou J, Fried LP (2009) Executive decline and dysfunction precedes declines in memory: the Women’s Health and Aging Study II. J Gerontol 64:110–117

    Google Scholar 

  11. Dubois B, Pilon B, Lhermitte F, Agid Y (1990) Cholinergic deficiency and frontal dysfunction in Parkinson’s disease. Ann Neurol 28:117–121. doi:10.1002/ana.410280202

    Article  PubMed  CAS  Google Scholar 

  12. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707. doi:10.1002/mds.21507 quiz 1837

    Article  PubMed  Google Scholar 

  13. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: S Fahn, CD Marsden, Calne DB, Lieberman A (eds) Recent developments in Parkinson disease. Macmillan Health Care information, Florham Park, pp 153–163

    Google Scholar 

  14. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198. doi:10.1016/0022-3956(75)90026-6

    Article  PubMed  CAS  Google Scholar 

  15. Freedman M, Leach L, Kaplan E, Winocur G, Schulman KI, Delis DC (1994) Clock drawing: a neuropsychological analysis. Oxford University Press, New York

    Google Scholar 

  16. Guerreiro M, Silva AP, Botelho MA, Leitão O, Castro-Caldas A, Garcia C (1994) Translation and adaptation to Portuguese population of the mini mental state examination (MMSE). Rev Port Neurol 3(Suppl. 1):9

    Google Scholar 

  17. Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United Kingdom. Mov Disord 19:1043–1049. doi:10.1002/mds.20216

    Article  PubMed  Google Scholar 

  18. Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RH, Spokes EG (2000) A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology 54:1596–1602

    PubMed  CAS  Google Scholar 

  19. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I et al (1990) Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson study group. Neurology 40:1529–1534

    PubMed  CAS  Google Scholar 

  20. Kalbe E, Calabrese P, Kohn N, Hilker R, Riedel O, Wittchen HU, Dodel R, Otto J, Ebersbach G, Kessler J (2008) Screening for cognitive deficits in Parkinson’s disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord 14:93–101. doi:10.1016/j.parkreldis.2007.06.008

    Article  PubMed  Google Scholar 

  21. Kompoliti K, Wang QE, Goetz CG, Leurgans S, Raman R (2000) Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson’s disease. Neurology 54:458–462

    PubMed  CAS  Google Scholar 

  22. Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson’s disease. Brain 106(Pt 2):257–270. doi:10.1093/brain/106.2.257

    Article  PubMed  Google Scholar 

  23. Levy G, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K (2000) Motor impairment in PD: relationship to incident dementia and age. Neurology 55:539–544

    PubMed  CAS  Google Scholar 

  24. Lezak MD (1995) Neuropsychological Assessment. Oxford University Press, Oxford

    Google Scholar 

  25. Locascio JJ, Corkin S, Growdon JH (2003) Relation between clinical characteristics of Parkinson’s disease and cognitive decline. J Clin Exp Neuropsychol 25:94–109. doi:10.1076/jcen.25.1.94.13624

    Article  PubMed  Google Scholar 

  26. Lyros E, Messinis L, Papathanasopoulos P (2008) Does motor subtype influence neurocognitive performance in Parkinson’s disease without dementia? Eur J Neurol 15:262–267. doi:10.1111/j.1468-1331.2007.02046.x

    Article  PubMed  CAS  Google Scholar 

  27. Mayeux R, Chen J, Mirabello E, Marder K, Bell K, Dooneief G, Cote L, Stern Y (1990) An estimate of the incidence of dementia in idiopathic Parkinson’s disease. Neurology 40:1513–1517

    PubMed  CAS  Google Scholar 

  28. Molloy SA, Rowan EN, O’Brien JT, McKeith IG, Wesnes K, Burn DJ (2006) Effect of levodopa on cognitive function in Parkinson’s disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 77:1323–1328. doi:10.1136/jnnp.2006.098079

    Article  PubMed  CAS  Google Scholar 

  29. Pillon B, Dubois B, Cusimano G, Bonnet AM, Lhermitte F, Agid Y (1989) Does cognitive impairment in Parkinson’s disease result from non-dopaminergic lesions? J Neurol Neurosurg Psychiatry 52:201–206. doi:10.1136/jnnp.52.2.201

    Article  PubMed  CAS  Google Scholar 

  30. Raven J (2000) The Raven’s progressive matrices: change and stability over culture and time. Cogn Psychol 41:1–48. doi:10.1006/cogp.1999.0735

    Article  PubMed  CAS  Google Scholar 

  31. Riecker A, Mathiak K, Wildgruber D, Erb M, Hertrich I, Grodd W, Ackermann H (2005) fMRI reveals two distinct cerebral networks subserving speech motor control. Neurology 64:700–706

    PubMed  CAS  Google Scholar 

  32. Riedel O, Klotsche J, Spottke A, Deuschl G, Forstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen HU (2008) Cognitive impairment in 873 patients with idiopathic Parkinson’s disease. Results from the German Study on Epidemiology of Parkinson’s Disease with Dementia (GEPAD). J Neurol 255:255–264. doi:10.1007/s00415-008-0720-2

    Article  PubMed  Google Scholar 

  33. Schwab RS, England AC (1969) Projection technique for evaluating surgery in Parkinson’s disease. In: Gillingham FJ, Donaldson IML (eds) Third Symposium in Parkinson’s Disease. Livingstone, Edinburgh, pp 152–157

  34. Shulman KI (2000) Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15:548–561. doi:10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U

    Article  PubMed  CAS  Google Scholar 

  35. Strub RL, Black FW (2000) The mental status examination in neurology. FA Davis Company, Philadelphia

    Google Scholar 

  36. Taylor JP, Rowan EN, Lett D, O’Brien JT, McKeith IG, Burn DJ (2008) Poor attentional function predicts cognitive decline in patients with non-demented Parkinson’s disease independent of motor phenotype. J Neurol Neurosurg Psychiatry 79:1318–1323. doi:10.1136/jnnp.2008.147629

    Article  PubMed  Google Scholar 

  37. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, Middelkoop HA, van Hilten JJ (2007) Cognitive impairment in Parkinson’s disease. J Neurol Neurosurg Psychiatry 78:1182–1187. doi:10.1136/jnnp.2006.112367

    Article  PubMed  CAS  Google Scholar 

  38. Wechsler D (1997) Wechsler adult intelligence scale-III. The Psychological Corporation, San Antonio

    Google Scholar 

  39. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain 130:1787–1798. doi:10.1093/brain/awm111

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Miguel Fernandes Gago.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gago, M.F., Garrett, M.C., Fonseca, M.R. et al. How do cognitive and axial motor signs correlate in Parkinson’s disease? A 6-year prospective study. J Neurol 256, 1655–1662 (2009). https://doi.org/10.1007/s00415-009-5174-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-5174-7

Keywords

Navigation